CNTG News and Press, Centogene N.V. From 10/06/22

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced its partnering conference schedule for October 2022. Compa...

Working together with Denali Therapeutics to accelerate data-driven precision medicine for the PD community Rostock International Parkinson's Disease (ROPAD) Study aims to characterize the genetics of PD to establish a better understanding of the disease progression, diagnosis, an...

The following slide deck was published by Centogene N.V. in conjunction with this event. For further details see: Centogene (CNTG) presents at H.C. Wainwright 24th Annual Global Investment Conference - Slideshow

Dammam Valley and Arcensus GmbH to establish Saudi-German Genomic Center in Riyadh DAMMAM, SAUDI ARABIA, Sept 8, 2022 - (ACN Newswire) - Dammam Valley, in partnership with other investment partners, and Arcensus GmbH announce the establishment of a high-throughput Saudi-German...

Dammam Valley/KSA to acquire the majority of Arcensus GmbH/Germany to accelerate the global implementation of Whole Genome Sequencing in genetic diagnostics and delivery of breakthrough technologies in genomic bioinformatics ROSTOCK, Germany & DAMMAM, KSA, Sept 5, 2022 - (...

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced its investment and partnering conference schedule for Sept...

Gainers: Redbox Entertainment ( RDBX ) +100% . Nano Labs ( NA ) +86% . FaZe ( FAZE ) +42% . Koss Corporation ( KOSS ) +35% . SpringBig Holdings ( SBIG ) +31% . Infrastructure and Energy Alternatives ( IEA ) +31% . ...

Centogene press release ( NASDAQ: CNTG ): Q1 GAAP EPS of -€0.28. Revenue of €10.32M (+3.4% Y/Y). For further details see: Centogene GAAP EPS of -€0.28, revenue of €10.32M

On Track for FY 2022 Guidance Q1 2022 revenue rises 3% to €10.3 million Completed phase out of COVID-19 Business segment in Q1 2022 Positioning Pharma and Diagnostics for post-COVID recovery and growth in 2022 and beyond Reaffirms FY 2022 guidance ...

Centogene (NASDAQ:CNTG) said on Monday it had appointed Miguel Coego Rios as Managing Director and Chief Financial Officer of the Company, effective June 22. Rios joined Centogene as EVP Finance & Legal in February 2022 and served as Interim Chief Financial Officer as of April 1, the...